Prevention of Recurrent Venous Thromboembolism (PREVENT)
Status:
Completed
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
A multicenter randomized, double blind placebo controlled trial to determine the efficacy of
long-term, low dose warfarin in the secondary prevention of venous thromboembolism.